Literature DB >> 18248299

Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver.

Sandra Ciesek1, Fabian A Helfritz, Ulrich Lehmann, Thomas Becker, Christian P Strassburg, Michael Neipp, Ayse Ciner, Paraskevi Fytili, Hans L Tillmann, Michael Peter Manns, Heiner Wedemeyer.   

Abstract

Occult hepatitis B is defined as the persistence of hepatitis B virus (HBV) DNA in persons without HBV surface antigen (HBsAg). The primary site for HBV persistence in persons with occult hepatitis B is considered to be the liver. We provide virological and immunological evidence for long-term persistence of HBV, even after removal of the infected liver, in 25 consecutive, randomly selected liver transplant recipients who tested positive for anti-HBV core antigen (anti-HBcAg) and negative for HBsAg at the time of transplantation. Furthermore, in a cohort of 101 anti-HBcAg-positive/HBsAg-negative patients, 2 showed clinical HBV reactivation after transplantation. Thus, these data indicate that a long-term extrahepatic HBV reservoir exists, which is relevant not only for liver transplantation but also for other types of transplantations, including bone marrow grafting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248299     DOI: 10.1086/525286

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

2.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

3.  Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-κB pathway.

Authors:  Jian Bo; Xiaojuan Wang; Jie Li; Wenqing Wang; Jinqian Zhang
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

4.  Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.

Authors:  Kang-Xian Luo; Fu-Yuan Zhou; Ding-Li Liu; Xiao-Rong Feng
Journal:  World J Hepatol       Date:  2010-12-27

5.  Characterization of occult hepatitis B infection among Iranian liver transplant recipients.

Authors:  Azam Khamseh; Vahdat Poortahmasebi; Saber Soltani; Mohsen Nasiritoosi; Ali Jafarian; Azam Ghaziasadi; Mehdi Norouzi; Saied Ghorbani; Narges Eslami; Seyed Mohammad Jazayeri
Journal:  J Clin Lab Anal       Date:  2022-09-09       Impact factor: 3.124

6.  Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance.

Authors:  M Ghabril; R C Dickson; M Krishna; R Lloyd; J Aranda-Michel; A Keaveny; R Satyanarayana; H Bonatti
Journal:  J Transplant       Date:  2009-05-05

7.  Occult Hepatitis B (OBH) in Clinical Settings.

Authors:  Seyed Moayed Alavian; Seyed Mohammad Miri; F Blaine Hollinger; Seyed Mohammad Jazayeri
Journal:  Hepat Mon       Date:  2012-08-25       Impact factor: 0.660

8.  Hepatitis B Virus Replication in CD34+ Hematopoietic Stem Cells From Umbilical Cord Blood.

Authors:  Yanxin Huang; Qin Yan; Rongshan Fan; Shupeng Song; Hong Ren; Yongguo Li; Yinghua Lan
Journal:  Med Sci Monit       Date:  2016-05-18

Review 9.  Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Authors:  Youxi Yu; Xiaoju Shi; Xingtong Wang; Ping Zhang; Ou Bai; Yan Li
Journal:  Cell Biosci       Date:  2022-03-12       Impact factor: 7.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.